Randomized trial comparing pantoprazole infusion, bolus and no treatment on gastric pH and recurrent bleeding in peptic ulcers.
Hung, Wai-Ka; Li, Vicky K M; Chung, Chi-Kin; Ying, Marcus W L; Loo, Ching-Kong; Liu, Cecilia K T; Lam, Billy Y K; Chan, Miranda C M.
ANZ J Surg
; 77(8): 677-81, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17635283
A randomized controlled trial comparing two different dosages of infusional pantoprazole in peptic ulcer bleeding.
Intravenous pantoprazole as an adjuvant therapy following successful endoscopic treatment for peptic ulcer bleeding.
Intravenous non-high-dose pantoprazole is equally effective as high-dose pantoprazole in preventing rebleeding among low risk patients with a bleeding peptic ulcer after initial endoscopic hemostasis.
Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleeding.
Inhibidores de la bomba de protones por vía intravenous en la hemorragia por úlcera péptica: es necesaria la supresión ácida máxima para disminuir el resangrado?
Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high- or low-risk stigmata.
Intermittent versus continuous pantoprazole infusion in peptic ulcer bleeding: a prospective randomized study.
Intravenous pantoprazole utilization in a level 1 trauma center.
Effect of proton pump inhibitors on the outcomes of peptic ulcer bleeding: comparison of event rates in routine clinical practice and a clinical trial.
Randomized controlled trial of high dose bolus versus continuous intravenous infusion pantoprazole as an adjunct therapy to therapeutic endoscopy in massive bleeding peptic ulcer.